Therapy Areas: AIDS & HIV
18 March 2019 - - The US Food and Drug Administration has accepted for review the company's New Drug Application for its higher naloxone injection product candidate for the treatme...
15 March 2019 - - Canada-based therapeutic antibodies developer AbCellera has inked a two-year agreement with the Bill and Melinda Gates Foundation to help accelerate global health research, the ...
14 March 2019 - Andreessen Horowitz-backed clinical laboratory Shield Diagnostics revealed on Wednesday the availability of the rapid molecular test Target-NG for antibiotic susceptibility in Neisseri...
13 March 2019 - - The first patient has been dosed in the open-label, Phase 1 clinical trial of RP-L102, US-based multi-platform gene therapy company Rocket Pharmaceuticals, Inc.'s (NASDAQ: ...
11 March 2019 - United States-based Gilead Sciences has revealed findings from two studies that support the further development of GS-6207, a novel, selective, first-in-class inhibitor of HIV-1 capsid...
8 March 2019 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has received results from the DISCOVER trial, a two-year Phase 3 randomized, controlled, double-blind study eva...